World Meningitis Day

It starts fast. It hits hard. And in a matter of hours, it can change a life forever.

Meningitis – particularly bacterial meningitis – remains one of the most severe and time-critical infectious diseases worldwide. Despite advances in treatment and prevention, its impact is still profound, even in high-resource settings.

In Europe, incidence rates range from 1 to 3 cases per 100,000 people each year. Yet the consequences go far beyond these numbers. Mortality can reach up to 15% even with appropriate treatment, and among survivors, as many as 1 in 5 will experience long-term complications, including neurological damage, hearing loss, or cognitive impairment.

These are not just statistics. They are a clear reminder of how urgent and complex meningitis management remains.

Early. Accurate. Decisive.

This is what effective clinical response demands and what modern diagnostics must deliver.

Our EuSepScreen Plus and EuSepScreen Lattanti detection kits are designed to support clinicians and laboratories in this critical window, enabling rapid multiplex detection of the most relevant bacterial pathogens, including Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae, Klebsiella pneumoniae, Escherichia coli, Streptococcus agalactiae, and Listeria monocytogenes.

By providing fast, reliable, and comprehensive results, these tools help guide timely and targeted therapeutic decisions – when every hour matters.

Because in meningitis, speed is not just an advantage.
It is what changes outcomes.